Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2015/979515 http://scihub22266oqcxt.onion/10.1155/2015/979515 C4452311!4452311 !26090468     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=26090468 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26090468 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Biomed+Res+Int 2015 ; 2015 (ä): 979515 Nephropedia Template TP {{tp|p=26090468 |t=2015. Gut Microbiota: Association with NAFLD and Metabolic Disturbances |pdf=|usr=}}{{26090468 }} gab.com Text Gut Microbiota: Association with NAFLD and Metabolic Disturbances JO: Biomed Res Int http://www.kidney.de/pget.php?&tw=1&pmid=26090468 #FOAvip Nonalcoholic fatty liver disease is the hepatic expression of metabolic syndrome, being frequently associated with obesity, insulin resistance, and dyslipidemia. Recent lines of evidence have demonstrated a role of gut microbiota in insulin resistance, obesity, and associated metabolic disturbances, raising the interest in its relationship with NAFLD pathogenesis. Therefore, intestinal microbiota has emerged as a potential factor involved in NAFLD, through different pathways, including its influence in energy storage, lipid and choline metabolism, ethanol production, immune balance, and inflammation. The main objective of this review is to address the pathogenic association of gut microbiota to NAFLD. This comprehension may allow the development of integrated strategies to modulate intestinal microbiota in order to treat NAFLD. Twit Text FOAVip Gut Microbiota: Association with NAFLD and Metabolic Disturbances ????Biomed Res Int http://www.kidney.de/pget.php?&tw=1&pmid=26090468 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26090468 #FOAvip English Wikipedia <ref>{{Cite pmid|26090468 }}</ref> Gut Microbiota: Association with NAFLD and Metabolic Disturbances #MMPMID26090468 Lau E ; Carvalho D ; Freitas P Biomed Res Int 2015[]; 2015 (ä): 979515 PMID26090468 show ga Nonalcoholic fatty liver disease is the hepatic expression of metabolic syndrome, being frequently associated with obesity, insulin resistance, and dyslipidemia. Recent lines of evidence have demonstrated a role of gut microbiota in insulin resistance, obesity, and associated metabolic disturbances, raising the interest in its relationship with NAFLD pathogenesis. Therefore, intestinal microbiota has emerged as a potential factor involved in NAFLD, through different pathways, including its influence in energy storage, lipid and choline metabolism, ethanol production, immune balance, and inflammation. The main objective of this review is to address the pathogenic association of gut microbiota to NAFLD. This comprehension may allow the development of integrated strategies to modulate intestinal microbiota in order to treat NAFLD. |*Gastrointestinal Microbiome [MESH] |Host-Pathogen Interactions [MESH] |Humans [MESH] |Inflammation/metabolism/microbiology/physiopathology [MESH] |Insulin Resistance [MESH] |Liver/*metabolism/microbiology/pathology [MESH] |Metabolic Syndrome/microbiology/*physiopathology [MESH]Gut Microbiota: Association with NAFLD and Metabolic Disturbances (epmc).pdf DeepDyve Pubget Overpricing